Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 67, 2003 - Issue 6
Journal homepage
335
Views
42
CrossRef citations to date
0
Altmetric
Original Articles

Promoting Effect of Kaempferol on the Differentiation and Mineralization of Murine Pre-osteoblastic Cell Line MC3T3-E1

Masaki MIYAKEFujisaki Institute, Hayashibara Biochemical Laboratories Inc.675-1 Fujisaki, Okayama 702-8006, Japan
,
Norie ARAIFujisaki Institute, Hayashibara Biochemical Laboratories Inc.675-1 Fujisaki, Okayama 702-8006, Japan
,
Shimpei USHIOFujisaki Institute, Hayashibara Biochemical Laboratories Inc.675-1 Fujisaki, Okayama 702-8006, Japan
,
Kanso IWAKIFujisaki Institute, Hayashibara Biochemical Laboratories Inc.675-1 Fujisaki, Okayama 702-8006, Japan
,
Masao IKEDAFujisaki Institute, Hayashibara Biochemical Laboratories Inc.675-1 Fujisaki, Okayama 702-8006, Japan
&
Masashi KURIMOTOFujisaki Institute, Hayashibara Biochemical Laboratories Inc.675-1 Fujisaki, Okayama 702-8006, Japan
Pages 1199-1205 | Received 12 Aug 2002, Accepted 16 Jan 2003, Published online: 22 May 2014

  • 1) Mizuno, T., “Nippon Yakusou Zensho” (in Japanese), Shin Nippon Houki, p. 5 (1995).
  • 2) Kimoto, T., Koya, S., Hino, K., Yamamoto, Y., Aga, H., Hashimoto, T., Masaki, N., Mukai, N., Hanaya, T., Arai, S., Ikeda, M., Fukuda, S., and Kurimoto, M., Protection by indigo plant (Polygonum tinctorium Lour.) against renal oxidative damage in mice treated with ferric nitrilotriacetate. Natural Medicines (in Japanese), 53, 291-296 (1999).
  • 3) Kimoto, T., Yamamoto, Y., Hino, K., Koya, S., Aga, H., Hashimoto, T., Hanaya, T., Arai, S., Ikeda, M., Fukuda, S., and Kurimoto, M., Cytotoxic effects of substances in indigo plant (Polygonum tinctorium Lour.) on malignant tumor cells. Natural Medicines (in Japanese), 53, 72-79 (1999).
  • 4) Ishihara, T., Kohno, K., Ushio, S., Iwaki, K., Ikeda, M., and Kurimoto, M., Tryptanthrin inhibits nitric oxide and prostaglandin E(2) synthesis by murine macrophages. Eur. J. Pharmacol., 407, 197-204 (2000).
  • 5) Ishihara, T., Okura, T., Kohno, K., Tanimoto, T., Ikegami, H., and Kurimoto, M., Polygonum tinctorium extract suppresses nitric oxide production by activated macrophages through inhibiting inducible nitric oxide synthase expression. J. Ethnopharmacol., 72, 141-150 (2000).
  • 6) Hashimoto, T., Aga, H., Chaen, H., Fukuda, S., and Kurimoto, M., Isolation and identification of anti-Helicobacter pylori compounds from Polygonum tinctorium Lour. Natural Medicines, 53, 27-31 (1999).
  • 7) Kataoka, M., Hirata, K., Kunikata, T., Ushio, S., Iwaki, K., Ohashi, K., Ikeda, M., and Kurimoto, M., Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbilis. J. Gastroenterol., 36, 5-9 (2001).
  • 8) Tatefuji, T., Aga, M., Kunikata, T., Ikeda, M., and Kurimoto, M., Antiviral effect of Polygonum tinctorium Lour. extracts on virus-infected cells. Natural Medicines, 53, 297-301 (1999).
  • 9) Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. A., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4263 (1998).
  • 10) Breinholt, V., Hossaini, A., Svensen, G. W., Brouwer, C., and Nielsen, S. E., Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem. Toxicol., 38, 555-564 (2000).
  • 11) Roth, A., Schaffner, W., and Hertel, C., Phytoestrogen kaempferol (3,4′,5,7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity. J. Neuroscience Res., 57, 399-404 (1999).
  • 12) Felsen, D. T., Zhang, Y., Hannan, M. T., Kiel, D. P., Wilson, P. W., and Anderson, J. J., The effect of postmenopausal estrogen therapy on bone density in elderly woman. N. Engl. J. Med., 329, 1141-1146 (1993).
  • 13) Sagraves, R., Estrogen therapy for postmenopausal symptoms and prevention of osteoporosis. J. Clin. Pharmacol., 35, 2S-10S (1995).
  • 14) Sudo, H., Kodama, H., Amagi, Y., Yamamoto, S., and Kasai, S., In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell. Biol., 96, 191-198 (1983).
  • 15) Kajii, T., Suzuki, K., Yoshikawa, M., Imai, T., Matsumoto, A., and Nakamura, S., Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch. Oral Biol., 44, 233-241 (1999).
  • 16) Hagiwara, H., Naruse, M., Adachi, C., Inoue, A., Hiruma, Y., Otsuka, E., Naruse, K., Demura, H., and Hirose, S., Ipriflavone down-regulates endothelin receptor levels during differentiation of rat calvarial osteoblast-like cells. J. Biochem. (Tokyo), 126, 168-173 (1999).
  • 17) Prabhakar, U., James, I. E., Dodds, R. A., Lee-Rykaczewski, E., Rieman, D. J., Lipshutz, D., Trulli, S., Jonak, Z., Tan, K. B., Drake, F. H., and Gowen, M., A novel human bone marrow stroma-derived cell line TF274 is highly osteogenic in vitro and in vivo. Calcif. Tissue Int., 63, 214-220 (1998).
  • 18) Stein, G. S., and Lian, J. B., Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev., 14, 424-442 (1993).
  • 19) Benvenuti, S., Tanini, A., Frediani, U., Bianchi, S., Masi, L., Casano, R., Bufalino, L., Serio, M., and Brandi, M. L., Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. J. Bone Miner. Res., 6, 987-996 (1991).
  • 20) Notoya, K., Yoshida, K., Tsukuda, R., and Taketomi, S., Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture. J. Bone Miner. Res., 9, 395-400 (1994).
  • 21) Cheng, S. L., Zhang, S. F., Nelson, T. L., Warlow, P. M., and Civitelli, R., Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif. Tissue Int., 55, 356-362 (1994).
  • 22) Petilli, M., Fiorelli, G., Benvenuti, S., Frediani, U., Gori, F., and Brandi, M. L., Interactions between ipriflavone and the estrogen receptor. Calcif. Tissue Int., 56, 160-165 (1995).
  • 23) Toesca, A., Pagnotta, A., and Specchia, N., Evidence of type II estrogen receptor in human osteoblast-like cells. Cell Biol. Int., 24, 303-309 (2000).
  • 24) Saito, M., Pharmacokinetic study of ipriflavone (TC-80) by oral administration in healthy male volunteers. Jpn. Pharmacol. Ther. (in Japanese), 13, 7223-7233 (1985).
  • 25) de Vries, J. H. M., Hollman, P. C. H., Meyboom, S., Buysman, M. N. C. P., Zock, P. L., Van Staveren, W. A., and Katan, M. B., Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am. J. Clin. Nutr., 68, 60-65 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.